Ryan Fuhrmann

Ryan Fuhrmann

InvestorPlace Contributor

Ryan C. Fuhrmann, CFA, has a background in portfolio management, overseeing assets for high-net-worth individuals and covering a broad array of industries from a generalist perspective. An active student of investing, he is also committed to communicating his ideas as an investment writer and learning from the financial community. His Twitter handle is @rationalanalyst.

Recent Articles

First Solar, Inc. (FSLR) Stock Could Really Burn You

By Ryan Fuhrmann, InvestorPlace Contributor

First Solar's investment potential is about as likable as relying on an outdated coal plant as an energy source - avoid FSLR stock.

Teva Pharmaceutical Industries Ltd (ADR) (TEVA): Nibble on Its Dividend and Wait

By Ryan Fuhrmann, InvestorPlace Contributor

Teva Pharmaceutical (TEVA) is perhaps the poster child for what can go wrong with an investment. But TEVA stock is cheap and could double in price.

Advanced Micro Devices, Inc. (AMD) Stock Isn’t Worth the Hype

By Ryan Fuhrmann, InvestorPlace Contributor

AMD stock was a monster play for about 18 months. Now, the market is deciding how much of Advanced Micro Devices' ascent was built on hype.

Is BP plc (ADR) (BP) Stock Actually Beating the Competition?

By Ryan Fuhrmann, InvestorPlace Contributor

It's safe to assume BP can easily survive in the current low-price environment. Which makes BP stock standout from its peers.

Why Twitter Inc (TWTR) Stock Is STILL a Big, Fat Dud

By Ryan Fuhrmann, InvestorPlace Contributor

There are still many reasons to think Twitter stock could get its act together. But at this point, other tech stocks are more stable than TWTR stock.

Sears Holdings Corp (SHLD) Stock Should Have Liquidated Long Ago

By Ryan Fuhrmann, InvestorPlace Contributor

Sears (SHLD) should have liquidated long ago, which could have left sizable real estate value for investors and brought relief to SHLD stock.

Micron Technology, Inc. (MU) Stock Is Cheap for a Reason

By Ryan Fuhrmann, InvestorPlace Contributor

Micron (MU) offers a bargain-basement valuation. However, it's hard to get excited over MU stock because of the overall business model.

Can Freeport-McMoRan Inc (FCX) Stock Escape This Grey Area?

By Ryan Fuhrmann, InvestorPlace Contributor

Freeport-McMoRan found itself the victim of investing in oil and gas properties just prior to the bottom falling out of oil. But FCX stock might still have a chance.

Vale SA (ADR) (VALE) Stock Has ‘Sleeper Hit’ Potential

By Ryan Fuhrmann, InvestorPlace Contributor

Vale (VALE) has ramped down its capex in the face of flagging growth, while its dividend yield could help investors gain 50% in VALE stock.

Valeant Pharmaceuticals Intl Inc (VRX) Stock Could More Than Double

By Ryan Fuhrmann, InvestorPlace Contributor

Valeant Pharmaceuticals believes it stabilized its business and will be in turnaround mode for years. For once, VRX stock deserves optimism.

Load More